The landscape of dementia analysis has evolved radically with the advent of innovative biomarkers, together with amyloid PET scans, tau imaging, and blood-primarily based exams that could detect Alzheimer's pathology yrs before signs and symptoms emerge. Although these technological improvements characterize extraordinary development in understandi